




Healthcare Industry News: AbsorbaTack
News Release - September 9, 2009
Covidien Introduces Two New Surgical Products for Hernia Repair at International Hernia Congress
Absorbable fixation device for open ventral hernia surgery and lightweight monofilament polyester mesh round out Covidien’s surgical device offering for all types of hernia repairNORTH HAVEN, CT - September 9, 2009 - (HSMN NewsFeed) - Covidien (NYSE: COV), a leading global provider of healthcare products, today introduced two new surgical products at the 4th Joint Meeting of the American Hernia Society and European Hernia Society in Berlin, Germany. The products were the AbsorbaTack(TM) 20 Short Fixation Device, part of a comprehensive system for open ventral hernia repair, and Parietex(TM) Lightweight Monofilament Polyester Mesh, a new mesh for inguinal and ventral hernia repair.
The AbsorbaTack(TM) Fixation Device and Parietex(TM) Composite Open Skirt (PCO OS) Mesh System for open ventral hernia repair combine the AbsorbaTack(TM) 20 Short, a new absorbable fixation device, with Parietex(TM) PCO OS mesh for a proven solution that adds no sharps in the OR for a safer surgical environment. The AbsorbaTack(TM) 20 Short features an easy-to-use 18.5cm short shaft that gives surgeons ergonomic access to the defect site and deploys absorbable tacks without the need for piloting sharps. The Parietex(TM) PCO OS skirted mesh provides the advantages of fast, strong tissue in-growth from compliant, hydrophilic polyester mesh and an outstanding barrier to visceral attachments to the implant through a resorbable porcine collagen film.
“As one of the most performed surgeries in the world, hernia repair is a major area of focus for Covidien,” said Dr. Michael Tarnoff, Chief Medical Affairs Officer, Surgical Devices, Covidien. “The AbsorbaTack(TM) 20 Short builds on a foundation of technical innovation that began with the launch of the highly successful AbsorbaTack(TM) line in early 2008. This new product rounds out our offering of absorbable fixation products for all types of hernia procedures, including open and laparoscopic ventral and inguinal hernia surgery, which together is changing the way surgeons approach soft tissue repair.”
The new Parietex(TM) Lightweight Monofilament Polyester Mesh for inguinal and ventral hernia repair offers all the clinical benefits of polyester in an elastic, lightweight monofilament knit for rapid tissue in-growth and lasting comfort.
Dr. Tarnoff added, “Like many other Covidien products, the Parietex(TM) Lightweight Monofilament Polyester Mesh and AbsorbaTack(TM) 20 Short were developed in close collaboration with the medical community to create instrumentation that addresses both the procedure-specific and intuitive needs of the surgeon and with the safety and comfort of the patient in mind.”
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2008 revenue of $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
Source: Covidien
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.